Catilusa, Florencia R.
HRN: 04-41-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
CLARITHROMYCIN 500MG (CAP)
10/10/2023
10/17/2023
PO
500mg
BID
CAP MR; PTB Presumptive; COPD
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes